Upgrades:
U.S. Bancorp (NYSE:USB) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating in a research report issued to clients and investors on Monday, Briefing.com reports. The brokerage currently has a $51.50 price objective on the financial services provider's stock. JPMorgan Chase & Co.'s price objective would suggest a potential upside of 12.35% from the company's previous close.
Several other analysts have also issued reports on the
company. TheStreet raised U.S. Bancorp from a "c" rating to a
"b-" rating in a research note on Thursday, October 15th. BidaskClub
raised U.S. Bancorp from a "hold" rating to a "buy" rating
in a research note on Saturday. Morgan Stanley upgraded U.S. Bancorp from an
"underweight" rating to an "equal weight" rating and set a
$57.00 price objective for the company in a research report on Monday, November
30th. Stephens upgraded U.S. Bancorp from an "equal weight" rating to
an "overweight" rating and boosted their price objective for the
company from $42.00 to $52.00 in a research report on Monday, November 30th.
Finally, Bank of America upgraded U.S. Bancorp from an "underperform"
rating to a "neutral" rating and boosted their price objective for
the company from $39.00 to $41.00 in a research report on Wednesday, October
7th. Eleven equities research analysts have rated the stock with a hold rating
and twelve have assigned a buy rating to the company. The company has a
consensus rating of "Buy" and an average target price of $47.13. Read
more …
The Clorox (NYSE:CLX) was upgraded by equities research analysts at Smith Barney Citigroup from a “neutral” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports. The firm presently has a $249.00 target price on the stock, up from their prior target price of $238.00. Smith Barney Citigroup’s price objective points to a potential upside of 22.62% from the company’s previous close.
Other equities analysts also recently issued reports about
the stock. JPMorgan Chase & Co. downgraded shares of The Clorox from an
“overweight” rating to a “neutral” rating and set a $235.00 target price for
the company. in a report on Friday, October 16th. They noted that the move was
a valuation call. ValuEngine downgraded shares of The Clorox from a “hold”
rating to a “sell” rating in a report on Tuesday, November 10th. DA Davidson
raised their target price on shares of The Clorox from $263.00 to $268.00 and
gave the company a “buy” rating in a report on Tuesday, November 3rd. Deutsche
Bank Aktiengesellschaft raised their target price on shares of The Clorox from
$223.00 to $227.00 and gave the company a “hold” rating in a report on Tuesday,
November 3rd. Finally, Wells Fargo & Company began coverage on shares of
The Clorox in a report on Monday, December 7th. They set an “overweight” rating
and a $250.00 target price for the company. Four analysts have rated the stock
with a sell rating, seven have assigned a hold rating and five have issued a
buy rating to the company’s stock. The company has an average rating of “Hold”
and an average price target of $220.53. Read
more …
Welltower (NYSE:WELL) was upgraded by KeyCorp from a “sector weight” rating to an “overweight” rating in a report released on Monday, The Fly reports. The firm currently has a $70.00 price objective on the real estate investment trust’s stock. KeyCorp’s price objective indicates a potential upside of 8.95% from the company’s previous close.
Other analysts have also recently issued research reports
about the stock. Wells Fargo & Company cut shares of Welltower from an
“overweight” rating to an “equal weight” rating and upped their price objective
for the company from $54.00 to $63.50 in a research report on Monday, November
16th. Barclays increased their price target on Welltower from $50.00 to $58.00
and gave the stock an “equal weight” rating in a report on Friday, September
4th. Mizuho cut Welltower from a “buy” rating to a “neutral” rating and lifted
their price objective for the company from $51.00 to $57.00 in a report on
Friday, October 16th. Berenberg Bank lowered Welltower from a “buy” rating to a
“hold” rating in a research report on Wednesday, December 2nd. Finally,
Scotiabank downgraded shares of Welltower from a “sector perform” rating to a
“sector underperform” rating and dropped their target price for the stock from
$59.00 to $57.00 in a report on Thursday, December 3rd. One research analyst
has rated the stock with a sell rating, eighteen have issued a hold rating and
four have issued a buy rating to the company’s stock. The company currently has
a consensus rating of “Hold” and a consensus price target of $57.64. Read
more …
American Water Works (NYSE:AWK) was upgraded by stock analysts at Bank of America from an "underperform" rating to a "neutral" rating in a research report issued on Monday, The Fly reports.
Other analysts also recently issued reports about the
company. Zacks Investment Research upgraded American Water Works from a
"hold" rating to a "buy" rating and set a $169.00 price
objective for the company in a report on Monday, November 9th. Janney
Montgomery Scott downgraded American Water Works from a "buy" rating
to a "neutral" rating in a report on Tuesday, October 13th. Barclays
upped their price objective on American Water Works from $138.00 to $173.00 and
gave the stock an "equal weight" rating in a report on Wednesday,
November 18th. Finally, HSBC upgraded American Water Works from a
"hold" rating to a "buy" rating and set a $175.00 price
target for the company in a report on Monday, November 9th. One equities
research analyst has rated the stock with a sell rating, five have given a hold
rating and six have issued a buy rating to the company's stock. The stock has a
consensus rating of "Hold" and an average price target of $145.92.
Shares of American Water Works stock opened at $148.28 on
Monday. American Water Works has a fifty-two week low of $92.00 and a fifty-two
week high of $172.56. The firm has a market cap of $26.88 billion, a PE ratio
of 40.62, a P/E/G ratio of 4.71 and a beta of 0.18. The business's fifty day
moving average is $155.39 and its two-hundred day moving average is $143.68.
The company has a quick ratio of 0.85, a current ratio of 0.87 and a
debt-to-equity ratio of 1.47. Read
more …
McDonald's (NYSE:MCD) was upgraded by equities researchers at UBS Group from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Monday, Briefing.com reports. The brokerage currently has a $240.00 target price on the fast-food giant's stock, up from their prior target price of $230.00. UBS Group's price target would indicate a potential upside of 15.52% from the stock's current price.
Other equities analysts also recently issued reports about
the stock. BMO Capital Markets increased their price objective on shares of
McDonald's from $235.00 to $240.00 and gave the company an
"outperform" rating in a research note on Tuesday, November 10th.
BTIG Research increased their target price on McDonald's from $220.00 to $245.00
and gave the company a "buy" rating in a research report on Friday,
October 9th. KeyCorp boosted their price target on McDonald's from $225.00 to
$235.00 and gave the stock an "overweight" rating in a research
report on Tuesday, November 10th. Telsey Advisory Group upped their price
objective on McDonald's from $230.00 to $250.00 and gave the stock an
"outperform" rating in a research note on Monday, November 2nd.
Finally, Wells Fargo & Company lifted their target price on McDonald's from
$222.00 to $244.00 and gave the company an "overweight" rating in a
research note on Thursday, October 1st. Seven research analysts have rated the
stock with a hold rating and twenty-one have given a buy rating to the
company's stock. McDonald's has an average rating of "Buy" and a
consensus target price of $229.08. Read
more …
Wells Fargo & Company (NYSE:WFC) was upgraded by Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a report issued on Monday, The Fly reports.
Several other equities research analysts have also recently
issued reports on the company. Odeon Capital Group upgraded Wells Fargo &
Company from a “hold” rating to a “buy” rating in a research report on
Wednesday, September 2nd. BMO Capital Markets dropped their target price on
Wells Fargo & Company from $35.00 to $31.00 and set a “market perform”
rating for the company in a research report on Friday, October 16th. UBS Group
upgraded Wells Fargo & Company from a “sell” rating to a “neutral” rating
and boosted their target price for the company from $21.00 to $24.00 in a
research report on Friday, September 11th. ValuEngine upgraded Wells Fargo
& Company from a “hold” rating to a “buy” rating in a report on Wednesday,
November 25th. Finally, Morgan Stanley upgraded Wells Fargo & Company from
an “equal weight” rating to an “overweight” rating and set a $40.00 price
target for the company in a report on Monday, November 30th. One equities
research analyst has rated the stock with a sell rating, fourteen have issued a
hold rating and twelve have given a buy rating to the company’s stock. The
company has a consensus rating of “Hold” and a consensus target price of
$32.11. Read
more …
Bristol-Myers Squibb (NYSE:BMY) was upgraded by investment analysts at The Goldman Sachs Group from a "buy" rating to a "conviction-buy" rating in a research note issued on Tuesday, The Fly reports.
Several other analysts have also recently commented on BMY.
TheStreet raised shares of Bristol-Myers Squibb from a "c+" rating to
a "b" rating in a research note on Monday, December 7th. Guggenheim
raised shares of Bristol-Myers Squibb from a "neutral" rating to a
"buy" rating and set a $70.00 target price for the company in a
research note on Monday, October 19th. Berenberg Bank initiated coverage on shares
of Bristol-Myers Squibb in a research note on Tuesday, September 29th. They
issued a "buy" rating and a $73.00 target price for the company.
Gabelli lowered shares of Bristol-Myers Squibb from a "buy" rating to
a "hold" rating in a report on Friday, November 6th. Finally, Smith
Barney Citigroup lifted their price target on shares of Bristol-Myers Squibb
from $73.00 to $77.00 in a report on Monday, November 30th. Two research
analysts have rated the stock with a sell rating, five have assigned a hold
rating, eleven have assigned a buy rating and one has issued a strong buy
rating to the company. Bristol-Myers Squibb presently has a consensus rating of
"Buy" and a consensus target price of $73.71. Read
more …
Medtronic (NYSE:MDT) was upgraded by stock analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report issued on Tuesday, Briefing.com reports. The firm presently has a $140.00 price target on the medical technology company’s stock. Morgan Stanley’s target price indicates a potential upside of 25.03% from the company’s current price.
A number of other research firms have also recently
commented on MDT. Smith Barney Citigroup boosted their price target on
Medtronic from $120.00 to $128.00 in a report on Wednesday, November 25th.
Cowen reaffirmed a “buy” rating and issued a $110.00 target price on shares of
Medtronic in a report on Tuesday, August 18th. Truist increased their price
target on Medtronic to $128.00 and gave the company a “buy” rating in a
research note on Wednesday, November 25th. BTIG Research increased their price
target on Medtronic from $119.00 to $124.00 and gave the company a “buy” rating
in a research note on Wednesday, November 25th. Finally, Raymond James upped
their target price on Medtronic from $115.00 to $122.00 and gave the company an
“outperform” rating in a research report on Wednesday, November 25th. Three
equities research analysts have rated the stock with a sell rating, two have
given a hold rating, twenty-one have assigned a buy rating and one has given a
strong buy rating to the stock. The stock presently has an average rating of
“Buy” and an average price target of $121.38. Read
more …
Exxon Mobil (NYSE:XOM) was upgraded by investment analysts at The Goldman Sachs Group from a "neutral" rating to a "buy" rating in a research note issued to investors on Tuesday, The Fly reports.
A number of other research analysts have also recently
weighed in on the company. Standpoint Research upgraded Exxon Mobil from a
"hold" rating to a "buy" rating in a research report on
Friday, September 11th. Credit Suisse Group reduced their price target on Exxon
Mobil from $47.00 to $37.00 and set a "neutral" rating on the stock
in a research report on Monday, November 2nd. Raymond James reaffirmed a
"sell" rating on shares of Exxon Mobil in a research report on
Friday, September 18th. Citigroup Inc. 3% Minimum Coupon Principal Protected
Based Upon Russell upped their price objective on Exxon Mobil from $33.00 to
$39.00 in a research note on Wednesday, December 9th. Finally, Wells Fargo
& Company upgraded Exxon Mobil from an "equal weight" rating to
an "overweight" rating and set a $53.00 price target for the company
in a research report on Tuesday. Four investment analysts have rated the stock
with a sell rating, twenty have given a hold rating and six have given a buy
rating to the company. The stock has an average rating of "Hold" and
a consensus target price of $47.24. Read
more …
The Southern (NYSE:SO) was upgraded by analysts at Scotiabank from a “sector perform” rating to an “outperform” rating in a research report issued on Tuesday, The Fly reports.
Other analysts have also recently issued reports about the
company. Mizuho upped their target price on The Southern from $48.00 to $53.00
in a report on Wednesday, October 28th. KeyCorp upped their target price on The
Southern from $65.00 to $66.00 and gave the company an “overweight” rating in a
report on Monday, October 19th. Morgan Stanley increased their price target on
The Southern from $60.00 to $62.00 and gave the stock an “underweight” rating
in a report on Tuesday, November 17th. Barclays increased their price target on
The Southern from $61.00 to $73.00 and gave the stock an “overweight” rating in
a report on Wednesday, November 18th. Finally, BMO Capital Markets began
coverage on The Southern in a report on Tuesday, November 24th. They set a
“market perform” rating and a $67.00 price target on the stock. Four investment
analysts have rated the stock with a sell rating, nine have issued a hold
rating and seven have issued a buy rating to the company’s stock. The company
currently has a consensus rating of “Hold” and an average price target of
$64.15. Read
more …
Dominion Energy (NYSE:D) was upgraded by equities researchers at Bank of America from a “neutral” rating to a “buy” rating in a note issued to investors on Wednesday, AR Network reports. The firm currently has a $83.00 price target on the utilities provider’s stock. Bank of America‘s price target would suggest a potential upside of 9.96% from the stock’s previous close.
D has been the subject of a number of other research
reports. Mizuho upgraded shares of Dominion Energy from an “underperform”
rating to a “neutral” rating and increased their target price for the stock
from $68.00 to $76.00 in a research report on Thursday, December 10th. BMO
Capital Markets upgraded shares of Dominion Energy from a “market perform”
rating to an “outperform” rating and lifted their target price for the stock
from $86.00 to $88.00 in a report on Monday, November 2nd. TheStreet upgraded
Dominion Energy from a “c+” rating to a “b-” rating in a research note on
Monday, November 2nd. UBS Group downgraded shares of Dominion Energy from a
“buy” rating to a “neutral” rating and lifted their price target for the stock
from $81.00 to $86.00 in a research note on Monday, November 9th. They noted
that the move was a valuation call. Finally, Zacks Investment Research cut
shares of Dominion Energy from a “buy” rating to a “hold” rating and set a
$84.00 price objective on the stock. in a research note on Thursday, October
29th. Twelve equities research analysts have rated the stock with a hold rating
and seven have issued a buy rating to the company’s stock. The company
presently has an average rating of “Hold” and a consensus price target of
$83.61. Read
more …
Raytheon Technologies (NYSE:RTX) was upgraded by equities researchers at DZ Bank from a “hold” rating to a “buy” rating in a report released on Thursday, Briefing.com reports. The brokerage presently has a $86.00 price objective on the stock. DZ Bank’s price target points to a potential upside of 21.86% from the company’s current price.
RTX has been the topic of a number of other reports.
JPMorgan Chase & Co. increased their price target on Raytheon Technologies
from $79.00 to $85.00 and gave the stock an “overweight” rating in a research
report on Tuesday. Credit Suisse Group decreased their price objective on
Raytheon Technologies from $75.00 to $70.00 and set an “outperform” rating for
the company in a report on Wednesday, October 28th. ValuEngine raised Raytheon
Technologies from a “sell” rating to a “hold” rating in a research note on
Tuesday, November 3rd. The Goldman Sachs Group raised Raytheon Technologies
from a “buy” rating to a “conviction-buy” rating in a research note on Sunday,
September 20th. Finally, Morgan Stanley started coverage on Raytheon
Technologies in a research note on Tuesday, September 8th. They set an
“overweight” rating and a $89.00 price target for the company. One investment
analyst has rated the stock with a sell rating, five have issued a hold rating,
thirteen have assigned a buy rating and one has given a strong buy rating to
the stock. Raytheon Technologies presently has an average rating of “Buy” and
an average price target of $86.78. Read
more …
Downgrades:
The Walt Disney (NYSE:DIS) was downgraded by BMO Capital Markets from an “outperform” rating to a “market perform” rating in a research note issued to investors on Monday, The Fly reports. They currently have a $185.00 price objective on the entertainment giant’s stock. BMO Capital Markets’ target price suggests a potential upside of 5.28% from the company’s previous close.
Several other equities analysts have also recently commented
on the company. Rosenblatt Securities increased their target price on The Walt
Disney from $145.00 to $155.00 and gave the company a “buy” rating in a
research note on Friday, November 13th. Moffett Nathanson increased their
target price on The Walt Disney from $118.00 to $136.00 and gave the company a
“neutral” rating in a research note on Thursday, October 1st. Citigroup raised
their price objective on The Walt Disney from $135.00 to $150.00 and gave the
stock a “buy” rating in a research note on Wednesday, August 19th. Barclays
raised their price objective on The Walt Disney from $150.00 to $185.00 in a
research note on Friday. Finally, KeyCorp raised their price objective on The
Walt Disney from $177.00 to $182.00 in a research note on Friday. Two research
analysts have rated the stock with a sell rating, eight have given a hold
rating and twenty-four have issued a buy rating to the company. The Walt Disney
has an average rating of “Buy” and an average target price of $153.47. Read
more …
W.W. Grainger (NYSE:GWW) was downgraded by research analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating in a research note issued to investors on Monday, The Fly reports.
Several other equities research analysts have also issued
reports on GWW. Stephens began coverage on shares of W.W. Grainger in a report
on Thursday, October 15th. They issued an "equal weight" rating for
the company. Morgan Stanley increased their price objective on shares of W.W.
Grainger from $366.00 to $401.00 and gave the company an "equal
weight" rating in a report on Friday, October 23rd. UBS Group increased
their price objective on shares of W.W. Grainger from $425.00 to $465.00 and
gave the company a "buy" rating in a report on Wednesday, November
18th. Oppenheimer increased their price objective on shares of W.W. Grainger
from $375.00 to $400.00 and gave the company an "outperform" rating
in a report on Wednesday, September 30th. Finally, William Blair lowered shares
of W.W. Grainger from an "outperform" rating to a "market
perform" rating in a report on Friday, November 20th. Two investment
analysts have rated the stock with a sell rating, seven have issued a hold
rating and eight have given a buy rating to the company's stock. The company
currently has an average rating of "Hold" and a consensus target
price of $364.86. Read
more …
Johnson Controls International (NYSE:JCI) was downgraded by research analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating in a research report issued on Monday, The Fly reports.
Other analysts have also recently issued research reports
about the company. TheStreet raised Johnson Controls International from a
"c+" rating to a "b" rating in a research report on
Thursday, October 22nd. Zacks Investment Research lowered Johnson Controls
International from a "buy" rating to a "hold" rating and
set a $44.00 price objective for the company. in a research note on Wednesday,
October 7th. Smith Barney Citigroup cut Johnson Controls International from a
"buy" rating to a "neutral" rating and set a $51.00 target
price on the stock. in a report on Monday. Citigroup Inc. 3% Minimum Coupon
Principal Protected Based Upon Russell lowered Johnson Controls International
from a "buy" rating to a "neutral" rating and set a $51.00
target price on the stock. in a research report on Monday. Finally, Credit
Suisse Group boosted their target price on Johnson Controls International from
$44.00 to $49.00 and gave the company an "outperform" rating in a
research report on Wednesday, November 4th. Nine analysts have rated the stock
with a hold rating and twelve have assigned a buy rating to the company's
stock. Johnson Controls International has a consensus rating of "Buy"
and a consensus price target of $44.28. Read
more …
L3Harris Technologies (NYSE:LHX) was downgraded by investment analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a note issued to investors on Tuesday, Briefing.com reports. They presently have a $215.00 price objective on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 13.19% from the company’s previous close.
LHX has been the subject of a number of other research
reports. The Goldman Sachs Group downgraded L3Harris Technologies from a
“conviction-buy” rating to a “buy” rating in a report on Sunday, September
20th. 140166 started coverage on L3Harris Technologies in a report on Monday.
They issued a “positive” rating and a $230.00 target price for the company.
Royal Bank of Canada reduced their target price on L3Harris Technologies from
$219.00 to $199.00 and set an “outperform” rating for the company in a report
on Monday, November 2nd. ValuEngine downgraded L3Harris Technologies from a
“hold” rating to a “sell” rating in a report on Thursday, October 1st. Finally,
Morgan Stanley initiated coverage on L3Harris Technologies in a research report
on Tuesday, September 8th. They issued an “overweight” rating and a $248.00
price target for the company. One equities research analyst has rated the stock
with a sell rating, two have given a hold rating and nineteen have assigned a
buy rating to the company. The stock has an average rating of “Buy” and a
consensus target price of $237.47. Read
more …
Chevron (NYSE:CVX) was downgraded by research analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a note issued to investors on Tuesday, Briefing.com reports. They presently have a $105.00 price objective on the oil and gas company’s stock. Wells Fargo & Company‘s price objective suggests a potential upside of 17.40% from the stock’s previous close.
A number of other research firms have also recently
commented on CVX. Scotiabank cut Chevron from a “sector outperform” rating to a
“sector perform” rating and set a $95.00 price target for the company. in a
report on Wednesday, September 23rd. Piper Sandler cut Chevron from an
“overweight” rating to a “neutral” rating and set a $108.00 price target for the
company. in a report on Monday, August 17th. ValuEngine upgraded Chevron from a
“hold” rating to a “buy” rating in a report on Wednesday, November 25th. Bank
of America upgraded shares of Chevron from a “neutral” rating to a “buy” rating
and set a $96.00 price objective for the company in a research report on
Monday, September 28th. Finally, Tudor Pickering downgraded shares of Chevron
from a “buy” rating to a “hold” rating in a research report on Monday, December
7th. Eleven investment analysts have rated the stock with a hold rating,
sixteen have given a buy rating and one has assigned a strong buy rating to the
company’s stock. The company currently has an average rating of “Buy” and an
average target price of $102.12. Read
more …
Amgen (NASDAQ:AMGN) was downgraded by The Goldman Sachs Group from a "conviction-buy" rating to a "buy" rating in a research report issued on Tuesday, The Fly reports.
AMGN has been the topic of a number of other reports. Piper
Sandler lifted their price objective on shares of Amgen from $270.00 to $280.00
and gave the stock an "overweight" rating in a research report on
Tuesday, December 8th. Royal Bank of Canada reaffirmed a "hold"
rating and issued a $223.00 price target on shares of Amgen in a report on
Thursday, October 15th. Mizuho cut their price target on shares of Amgen from
$260.00 to $215.00 and set a "neutral" rating for the company in a
research note on Monday, November 2nd. Sanford C. Bernstein lowered shares of
Amgen from an "outperform" rating to a "market perform"
rating in a report on Friday, October 9th. Finally, Cantor Fitzgerald decreased
their price objective on shares of Amgen from $279.00 to $278.00 and set an
"overweight" rating on the stock in a report on Thursday, October
29th. Three investment analysts have rated the stock with a sell rating, twelve
have issued a hold rating and seventeen have assigned a buy rating to the
company's stock. Amgen presently has an average rating of "Hold" and
a consensus target price of $254.31. Read
more …
Tyson Foods (NYSE:TSN) was downgraded by JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating in a report issued on Wednesday, The Fly reports. They presently have a $70.00 price target on the stock. JPMorgan Chase & Co.'s price objective would indicate a potential upside of 2.56% from the company's previous close.
Other research analysts also recently issued reports about
the stock. TheStreet raised shares of Tyson Foods from a "c+" rating
to a "b-" rating in a research report on Tuesday, August 25th.
ValuEngine upgraded shares of Tyson Foods from a "sell" rating to a
"hold" rating in a report on Saturday, December 5th. Piper Sandler
upgraded shares of Tyson Foods from a "neutral" rating to an
"overweight" rating and raised their price target for the stock from
$70.00 to $77.00 in a report on Thursday, December 3rd. Finally, BidaskClub
upgraded shares of Tyson Foods from a "hold" rating to a
"buy" rating in a report on Tuesday, December 8th. One equities
research analyst has rated the stock with a sell rating, eight have issued a
hold rating and six have given a buy rating to the stock. Tyson Foods presently
has a consensus rating of "Hold" and an average price target of
$78.73. Read
more …
Pfizer (NYSE:PFE) was downgraded by Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a report issued on Wednesday, The Fly reports. They presently have a $42.00 price target on the biopharmaceutical company’s stock, down from their previous price target of $43.00. Royal Bank of Canada’s price target suggests a potential upside of 8.50% from the company’s previous close.
A number of other brokerages have also issued reports on
PFE. Atlantic Securities lowered shares of Pfizer from an “overweight” rating
to a “neutral” rating and dropped their price target for the stock from $44.00
to $39.00 in a research note on Monday, October 12th. The Goldman Sachs Group
set a $40.00 target price on shares of Pfizer and gave the company a “neutral”
rating in a research note on Friday, December 11th. TheStreet upgraded Pfizer
from a “c+” rating to a “b-” rating in a research note on Wednesday, November
25th. Truist initiated coverage on Pfizer in a report on Friday, October 23rd.
They set a “buy” rating and a $42.00 target price on the stock. Finally,
JPMorgan Chase & Co. set a $36.00 target price on Pfizer and gave the stock
a “neutral” rating in a research report on Monday, November 9th. One analyst
has rated the stock with a sell rating, eleven have given a hold rating and
four have given a buy rating to the stock. The company currently has an average
rating of “Hold” and a consensus target price of $39.87. Read
more …
Fastenal (NASDAQ:FAST) was downgraded by equities research analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Wednesday, AnalystRatings.net reports. They currently have a $51.00 price objective on the stock. Deutsche Bank Aktiengesellschaft's price objective would indicate a potential upside of 2.35% from the stock's current price.
FAST has been the topic of a number of other research
reports. Raymond James downgraded Fastenal from a "market perform"
rating to an "underperform" rating in a research report on Friday,
September 4th. ValuEngine downgraded shares of Fastenal from a "hold"
rating to a "sell" rating in a research note on Thursday, October
1st. Stephens started coverage on shares of Fastenal in a research report on
Thursday, October 15th. They issued an "overweight" rating on the
stock. UBS Group began coverage on Fastenal in a report on Tuesday, September
15th. They set a "neutral" rating and a $44.00 target price for the
company. Finally, BidaskClub lowered Fastenal from a "buy" rating to
a "hold" rating in a research report on Thursday, December 10th. Two
research analysts have rated the stock with a sell rating, nine have given a
hold rating and three have given a buy rating to the company's stock. The stock
has a consensus rating of "Hold" and an average target price of
$44.27. Read
more …
AT&T (NYSE:T) was downgraded by equities researchers at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research note issued to investors on Thursday, Briefing.com reports. They currently have a $34.00 target price on the technology company’s stock. Morgan Stanley’s price target suggests a potential upside of 12.25% from the company’s previous close.
T has been the subject of a number of other reports.
BidaskClub raised AT&T from a “strong sell” rating to a “sell” rating in a
report on Thursday, December 10th. ValuEngine raised AT&T from a “strong
sell” rating to a “sell” rating in a report on Tuesday, December 1st. Barclays
assumed coverage on AT&T in a report on Friday, October 2nd. They issued an
“overweight” rating for the company. Royal Bank of Canada dropped their target
price on AT&T from $32.00 to $30.00 in a report on Monday, October 26th.
Finally, KeyCorp cut AT&T from a “sector weight” rating to an “underweight”
rating and set a $25.00 target price for the company. in a report on Monday,
October 5th. Six investment analysts have rated the stock with a sell rating,
nine have assigned a hold rating and thirteen have given a buy rating to the
stock. The company presently has a consensus rating of “Hold” and a consensus
target price of $32.42. Read
more …
Kinder Morgan (NYSE:KMI) was downgraded by Credit Suisse Group from an "outperform" rating to a "neutral" rating in a research note issued to investors on Thursday, Briefing.com reports. They currently have a $16.00 target price on the pipeline company's stock. Credit Suisse Group's target price would suggest a potential upside of 9.59% from the company's current price.
Several other research analysts have also issued reports on
the company. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon
Russell assumed coverage on Kinder Morgan in a research report on Thursday,
December 3rd. They set an "outperform" rating on the stock. Wolfe
Research lowered Kinder Morgan from a "peer perform" rating to an
"underperform" rating and increased their price objective for the company
from $13.00 to $14.00 in a report on Monday, November 23rd. Capital One
Financial initiated coverage on Kinder Morgan in a report on Wednesday, October
21st. They issued an "equal weight" rating on the stock. ValuEngine
raised Kinder Morgan from a "sell" rating to a "hold"
rating in a report on Tuesday, December 1st. Finally, Wells Fargo & Company
lowered Kinder Morgan from an "overweight" rating to an "equal
weight" rating and set a $17.00 price objective on the stock. in a report
on Monday, November 30th. One equities research analyst has rated the stock
with a sell rating, eleven have assigned a hold rating and eleven have issued a
buy rating to the company's stock. The stock presently has a consensus rating
of "Hold" and a consensus price target of $17.33. Read
more …
ViacomCBS (NASDAQ:VIAC) was downgraded by Bank of America from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Friday, The Fly reports. They presently have a $32.00 target price on the stock, up from their prior target price of $30.00. Bank of America‘s target price would suggest a potential downside of 11.60% from the stock’s previous close.
Other analysts have also recently issued reports about the
company. Needham & Company LLC raised their price target on ViacomCBS from
$30.00 to $36.00 and gave the company a “buy” rating in a report on Friday,
October 9th. Wells Fargo & Company raised ViacomCBS from an “underweight”
rating to an “equal weight” rating and raised their price target for the
company from $19.00 to $30.00 in a report on Thursday, August 27th. Zacks
Investment Research cut ViacomCBS from a “hold” rating to a “sell” rating and set
a $31.00 price objective for the company. in a report on Friday, November 13th.
Morgan Stanley lifted their price objective on ViacomCBS from $29.00 to $32.00
and gave the stock an “equal weight” rating in a report on Monday, November
2nd. Finally, Loop Capital started coverage on ViacomCBS in a report on
Thursday, October 1st. They set a “hold” rating and a $30.00 price objective
for the company. Five investment analysts have rated the stock with a sell
rating, ten have given a hold rating, ten have issued a buy rating and one has
assigned a strong buy rating to the company. The stock has an average rating of
“Hold” and an average target price of $33.29. Read
more …
Wow. Great content man. I think McDonald and Clorox is expensive. They should not be a buy at these prices.
ReplyDelete